Q4 FY2025 · Presentation 2
5 pages
Read Novo Nordisk A/S Class B's results firsthand
Preview the first 2 pages of this presentation
Create a free account to start reading
Full documents are included with Professional
Novo Nordisk A/S Class B
42.18
USD
+1.99
(+4.95%)
Novo Nordisk A/S Class B Documents
Q4 FY2025 documents
Annual report
Form 20-F · 43 pages
Feb 4, 2026
Annual report
137 pages
Feb 4, 2026
Interim report
Novo Nordisk - Q4 2025 - Interim Report
43 pages
Feb 4, 2026
Interim report
Novo Nordisk - Q4 2025 - Interim Report
43 pages
Feb 3, 2026
Presentation 1
121 pages
Presentation 2
5 pages
Presentation 3
5 pages
Presentation 4
AGM 2026 FINAL PRESENTATION 26 MAR
51 pages
Presentation 5
121 pages
Press release
4 pages